Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Smith

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Lancet. Haematology|July 13, 2024
Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 studyFranco Locatelli, Bulent Antmen, Hyoung Jin Kang, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901Stephen D Barrett, Alexander J Bridges, David T Dudley, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum productionLain-Yen Hu, Daniel Du, Jennifer Hoffman, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Lancet. Haematology|July 13, 2024
Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 studyFranco Locatelli, Bulent Antmen, Hyoung Jin Kang, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901Stephen D Barrett, Alexander J Bridges, David T Dudley, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum productionLain-Yen Hu, Daniel Du, Jennifer Hoffman, et al.
Pageof 3